Simultaneous deletion of 3′ETV6 and 5′EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review

[1]  M. Rai,et al.  Blastic plasmacytoid dendritic cell neoplasm , 2018, Clinical case reports.

[2]  L. Medeiros,et al.  Extramedullary Manifestations of Myeloid Neoplasms. , 2015, American journal of clinical pathology.

[3]  R. Goswami,et al.  Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant. , 2015, American journal of clinical pathology.

[4]  M. Bessho,et al.  Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocation , 2015, Blood Cancer Journal.

[5]  N. Gao,et al.  Blastic plasmacytoid dendritic cell neoplasm with leukemic manifestation and ETV6 gene rearrangement: A case report , 2015, Experimental and therapeutic medicine.

[6]  S. Gujral,et al.  Blastic plasmacytoid dendritic cell neoplasm: report of two pediatric cases. , 2015, Indian journal of pathology & microbiology.

[7]  T. Papadopoulou,et al.  Blastic Plasmacytoid Dendritic Cell Neoplasm: Single-Center Experience with Two Cases in One Year , 2014, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[8]  J. Cigudosa,et al.  Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm , 2014, Leukemia.

[9]  M. Kwon,et al.  A Rare Case of Acute Leukemic Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm without Cutaneous Lesions , 2014, Annals of laboratory medicine.

[10]  H. Üsküdar Teke,et al.  Blastic Plasmacytoid Dendritic Cell Leukemia Successfully Treated by Autologous Hematopoietic Stem Cell Transplantation to a Remission of 48-Month Duration , 2013, Case reports in hematology.

[11]  L. Jeffrey Medeiros,et al.  TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow , 2013, American journal of hematology.

[12]  L. Xue,et al.  Blastic plasmacytoid dendritic cell neoplasm with EWSR1 gene rearrangement , 2013, Journal of Clinical Pathology.

[13]  S. Verstovsek,et al.  Systemic mastocytosis with associated clonal hematological non‐mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components , 2013, American journal of hematology.

[14]  S. Pileri,et al.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study , 2013, Haematologica.

[15]  Gerardo Botti,et al.  Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors , 2013, Medical Oncology.

[16]  F. Jardin,et al.  Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. , 2011, Blood.

[17]  E. De Braekeleer,et al.  ETV6 fusion genes in hematological malignancies: a review. , 2012, Leukemia research.

[18]  M. Paulli,et al.  Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. , 2011, Blood.

[19]  M. Salama,et al.  An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder. , 2011, The American Journal of dermatopathology.

[20]  M. Lee,et al.  A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Initially Mimicking Cutaneous Lupus Erythematosus , 2010, Cancer research and treatment : official journal of Korean Cancer Association.

[21]  M. Speicher,et al.  Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. , 2010, The Journal of investigative dermatology.

[22]  R. Zadro,et al.  Pre‐B‐cell acute lymphoblastic leukemia with bulk extramedullary disease and chromosome 22 (EWSR1) rearrangement masquerading as Ewing sarcoma , 2010, Pediatric blood & cancer.

[23]  H. Meyerson,et al.  CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti‐CD22 antibodies to peripheral blood dendritic cells , 2009, Cytometry. Part B, Clinical cytometry.

[24]  L. Shaffer,et al.  Comprar ISCN 2009 - An International System for Human Cytogenetic Nomenclature | Marilyn L. Slovak | 9783805589857 | Karger AG , 2009 .

[25]  D. Sharma,et al.  Granulocytic sarcoma masquerading as Ewing's sarcoma: a diagnostic dilemma. , 2008, Journal of cancer research and therapeutics.

[26]  Ludger Hengst,et al.  The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy , 2008, Nature Reviews Cancer.

[27]  J. Khoury.  Ewing sarcoma family of tumors: a model for the new era of integrated laboratory diagnostics , 2008, Expert review of molecular diagnostics.

[28]  M. D. Del Rosario,et al.  CD4+/CD56+ Hematodermic Neoplasm: Blastic NK Cell Lymphoma in a 6-year-old Child: Report of a Case and Review of Literature , 2007, Journal of pediatric hematology/oncology.

[29]  Robert E. Brown,et al.  Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia). , 2006, Annals of clinical and laboratory science.

[30]  A. Bernasconi,et al.  Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome , 2006, Leukemia & lymphoma.

[31]  J. Khoury.  Ewing Sarcoma Family of Tumors , 2005, Advances in anatomic pathology.

[32]  S. Bohlander.  ETV6: a versatile player in leukemogenesis. , 2005, Seminars in cancer biology.

[33]  M. Teitell,et al.  Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. , 2005, American journal of clinical pathology.

[34]  Bernhard Hiller,et al.  CyDAS: a cytogenetic data analysis system , 2005, Bioinform..

[35]  K. Karube,et al.  Non-B, Non-T Neoplasms With Lymphoblast Morphology: Further Clarification and Classification , 2003, The American journal of surgical pathology.

[36]  L. Medeiros,et al.  Cytogenetic findings in blastoid mantle cell lymphoma. , 2003, Human pathology.

[37]  K. Anargyrou,et al.  An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia , 2003, European journal of haematology.

[38]  G. Freund,et al.  Dual sampling of the endocervix and its impact on AutoCyte Prep endocervical adequacy. , 2002, American journal of clinical pathology.

[39]  M. Callanan,et al.  CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. , 2002, Blood.

[40]  J. Manning,et al.  CD56+ TdT+ blastic natural killer cell tumor of the skin , 2002, Cancer.

[41]  C. Rakozy,et al.  Blastic natural killer cell lymphoma/leukemia: a report of seven cases. , 2002, American journal of clinical pathology.

[42]  P. M. Long,et al.  CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. , 2001, American journal of clinical pathology.

[43]  N. Carpenter,et al.  Molecular cytogenetics , 2001, Seminars in pediatric neurology.

[44]  T. Molina,et al.  CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). , 1999, The American journal of surgical pathology.

[45]  K. Ooya,et al.  A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature. , 1998, American journal of clinical pathology.

[46]  D. Louie,et al.  Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. , 1997, The American journal of surgical pathology.

[47]  W. C. Chan,et al.  Acute agranular CD4‐positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents , 1995, Cancer.

[48]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .